日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The diagnosis and management of portal hypertension in cirrhosis: The Gastroenterological Society of Australia consensus

肝硬化门静脉高压的诊断和治疗:澳大利亚胃肠病学会共识

Majumdar, Avik; Holmes, Jacinta; Roberts, Stuart K; Bhat, Purnima; Mitchell, Tim; Ramachandran, Jeyamani; O'Beirne, James; Walker, Sarah; Sawhney, Rohit; Jagarlamudi, Nishita; Jacob, Rachael; Gill, Madeleine; Thomas, James A; Bloom, Stephen; Gracen, Lucy; Kemp, William; Raj, Ashok; Thompson, Alexander J; Romero, Sarah; Doyle, Adam; Maher, Adrian; Pow, Richard; Robertson, Marcus; Tiwari, Neha; Tibballs, Jonathan; Lubel, John; Popuri, Radha; Testro, Adam; Valliani, Talal; Waller, Karen; Chapman, Brooke; Gupta, Rohit; Hey, Penelope; Keating, Shelley; Sinclair, Marie; Janko, Natasha; Koshy, Anoop; Majeed, Ammar; Mohammadi, Fadak; Fergusson, James; Furtado, Ruelan; MacQuillan, Gerry; Muller, Kate; Santhakumar, Cositha; Ahlenstiel, Golo; Strasser, Simone I

The Effect of Adhesive Systems on Shade Matching of Composite Veneer

粘合剂体系对复合树脂贴面颜色匹配的影响

Marar, Fadak Al; Aljarboua, Raghad; Alatiyyah, Fatimah M; AlGhamdi, Shahad; Farooqi, Faraz Ahmed; Almuhanna, Lama; AlSheikh, Rasha; Khan, Abdul Samad

Jascayd (nerandomilast): a novel PDE4B inhibitor for idiopathic pulmonary fibrosis

Jascayd(nerandomilast):一种用于治疗特发性肺纤维化的新型PDE4B抑制剂

Hujjat, Syeda Fadak Zahra; Chandani, Harshika Khaim; Chandani, Devya Khaim; Khan, Muhammad Saad; Mahmoud, Abubakr

Orexin receptor 2 agonists: a pathophysiologic approach to narcolepsy type 1

食欲素受体2激动剂:1型发作性睡病的病理生理学研究

Arif, Zainab; Siddiqui, Erum; Hujjat, Syeda Fadak Zahra; Khan, Muhammad Saad; Mauhmoud, Abubakr

The Next Frontier: Unveiling Novel Approaches for Combating Multidrug-Resistant Bacteria

下一个前沿领域:揭示对抗多重耐药菌的新方法

Mallari, Praveen; Rostami, Leila D; Alanko, Ida; Howaili, Fadak; Ran, Meixin; Bansal, Kuldeep K; Rosenholm, Jessica M; Salo-Ahen, Outi M H

The prevalence and contributing factors of NSAIDs prescription among chronic kidney disease patients in primary care: a mixed methods study from Kingdom of Bahrain

巴林王国初级保健机构慢性肾病患者非甾体抗炎药处方流行情况及影响因素:一项混合方法研究

Husain, Walaa A; Moosa, Rabab M; Awadh, Ameera M; Aladraj, Fadak M; Mahdi, Bayan; Haji, Shereen M; Chlif, Sadok; Alonge, Olakunle; Shehata, Mohamed H

Re-evaluating drug-coated balloon use in the elderly: a need for comparative and stratified insights

重新评估老年人使用药物涂层球囊:需要进行比较和分层分析

Zahra Hujjat, Syeda Fadak

Metabolic miracle or misguided shift? Tirzepatide in the era of obstructive sleep apnea (OSA)

代谢奇迹还是误入歧途?替拉帕肽在阻塞性睡眠呼吸暂停(OSA)时代的应用

Chandani, Devya Khaim; Chandani, Harshika Khaim; Khan, Muhammad Saad; Hujjat, Syeda Fadak Zahra; Waafira, Aminath

Harliku (nitisinone): first FDA-approved disease-modifying therapy for alkaptonuria

哈利库(尼替西酮):首个获得FDA批准的用于治疗尿黑酸症的疾病修饰疗法

Chandani, Harshika Khaim; Hujjat, Syeda Fadak Zahra; Chandani, Devya Khaim; Khan, Muhammad Saad; Mahmoud, Abubakr

Bruton's tyrosine kinase inhibition in ITP: Wayrilz (rilzabrutinib) as a disease-modifying strategy

ITP 中的布鲁顿酪氨酸激酶抑制:Wayrilz(rilzabrutinib)作为一种疾病修饰策略

Hujjat, Syeda Fadak Zahra; Chandani, Harshika Khaim; Khan, Muhammad Saad; Chandani, Devya Khaim; Mahmoud, Abubakr